Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Operating expenses:
Research and development expenses	$ 1,414,225	$ 1,886,934	$ 3,385,904	$ 2,916,937
General and administrative expenses	1,521,736	2,383,972	3,581,884	6,289,848
Total operating expenses	2,935,961	4,270,906	6,967,788	9,206,785
Loss from operations	(2,935,961)	(4,270,906)	(6,967,788)	(9,206,785)
Other income (expense):
Gain on bargain purchase upon merger	0	209,449	0	11,939,331
Interest income	6,617	175,605	53,036	198,907
Interest expense	0	0	0	(606)
Net (loss) income	(2,929,344)	(3,885,852)	(6,914,752)	2,930,847
Comprehensive (loss) income	$ (2,929,344)	$ (3,885,852)	$ (6,914,752)	$ 2,930,847
Per share information:
Net (loss) income per share, basic (in dollars per share)	$ (0.19)	$ (0.75)	$ (0.54)	$ 0.66
Net (loss) income per share, diluted (in dollars per share)	$ (0.19)	$ (0.75)	$ (0.54)	$ 0.52
Weighted average common shares outstanding, basic (in shares)	15,357,199	5,175,837	12,835,980	4,466,025
Weighted average common shares outstanding, diluted (in shares)	15,357,199	5,175,837	12,835,980	5,677,360